Literature DB >> 2085716

The effect of E. coli STa enterotoxin on the absorption of weakly dissociable drugs from rat proximal jejunum in vivo.

G T McEwan1, M L Lucas.   

Abstract

1. The effect of E. coli heat stable (STa) enterotoxin on the absorption of radio-labelled weak electrolytes and their appearance in peripheral blood was assessed in vivo by use of an intestinal recirculation procedure. 2. STa reduced the luminal disappearance (P less than 0.02) and peripheral blood appearance (P less than 0.02) of label from salicylic acid as well as the luminal disappearance (P less than 0.02) of diphenylhydantoin. 3. In contrast, STa increased the appearance in peripheral blood and disappearance from the lumen of label from morphine (P less than 0.05), amphetamine (P less than 0.01) and lignocaine (P less than 0.01). 4. Increased weak base (lignocaine) absorption can also be achieved by a combination of forskolin and theophylline which resembles STa in its ability to neutralise the usually acid surface pH of the proximal jejunum. 5. Increased weak base absorption and hindered weak acid absorption occurs despite a uniform reduction in net fluid absorption after STs exposure, making it unlikely that variations in fluid absorption account for the variations in drug absorption. 6. The ability of STa to elevate the mucosal surface pH (or acid microclimate) to neutral values, thereby altering the proportion of uncharged weak-electrolyte, may explain its different effects on weak acids and bases: neutralisation of the acid microclimate would increase the amount of undissociate weak base available for uptake.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085716      PMCID: PMC1917823          DOI: 10.1111/j.1476-5381.1990.tb14184.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Intestinal absorption of acidic beta-lactam antibiotics: contribution of ionized and un-ionized forms.

Authors:  J G Prieto; L Santos; J P Barrio; M L Alonso
Journal:  J Pharm Sci       Date:  1987-08       Impact factor: 3.534

2.  Gastrointestinal absorption of carbenoxolone in the rat determined in vitro and in situ: deviations from the pH-partition hypothesis.

Authors:  J W Bridges; J B Houston; M J Humphrey; W E Lindup; D V Parke; J S Shillingford; D G Upshall
Journal:  J Pharm Pharmacol       Date:  1976-02       Impact factor: 3.765

3.  The influence of pH, low sodium ion concentration and methotrexate on the jejunal-surface pH: a model for folic acid transfer.

Authors:  F H Lei; M L Lucas; J A Blair
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

4.  On the mechanism of intestinal absorption of drugs.

Authors:  C A HOGBEN; D J TOCCO; B B BRODIE; L S SCHANKER
Journal:  J Pharmacol Exp Ther       Date:  1959-04       Impact factor: 4.030

5.  The contribution of solvent drag to the intestinal absorption of the acidic drugs benzoic acid and salicylic acid from the jejunum of the rat.

Authors:  H Ochsenfahrt; D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Drug absorption IV: influence of pH on absorption kinetics of weakly acidic drugs.

Authors:  W G Crouthamel; G H Tan; L W Dittert; J T Doluisio
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

7.  Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates.

Authors:  R L Guerrant; J M Hughes; B Chang; D C Robertson; F Murad
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

8.  Preparation of whole blood for liquid scintillation counting.

Authors:  P A Moore
Journal:  Clin Chem       Date:  1981-04       Impact factor: 8.327

9.  Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption.

Authors:  W A Ritschel; G V Hammer
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-07

10.  Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP.

Authors:  M C Rao; S Guandalini; P L Smith; M Field
Journal:  Biochim Biophys Acta       Date:  1980-09-17
View more
  6 in total

1.  Evaluation of viability of excised rat intestinal segments in the Ussing chamber: investigation of morphology, electrical parameters, and permeability characteristics.

Authors:  B I Polentarutti; A L Peterson; A K Sjöberg; E K Anderberg; L M Utter; A L Ungell
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  The effect of E. coli STa enterotoxin on the absorption of weakly dissociable anti-malarial drugs from rat intestine in vivo.

Authors:  J M Rawlings; J Lynch; M L Lucas
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

3.  Escherichia coli heat stable (STa) enterotoxin and the upper small intestine: lack of evidence in vivo for net fluid secretion.

Authors:  M L Lucas; M M M Thom; J M Bradley; N F O'Reilly; T J McIlvenny; Y B Nelson
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

4.  Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.

Authors:  J Hunter; B H Hirst; N L Simmons
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 5.  Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function.

Authors:  D F McCole; K E Barrett
Journal:  Acta Physiol (Oxf)       Date:  2008-10-28       Impact factor: 6.311

6.  pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.

Authors:  Sibylle Neuhoff; Anna-Lena Ungell; Ismael Zamora; Per Artursson
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.